Hematopoietic and eosinophil-specific LNK(SH2B3) deficiency promotes eosinophilia and arterial thrombosis
Eosinophils promote arterial thrombosis in hematopoietic LNK deficiency.Eosinophil LNK is essential in suppression of arterial thrombosis.
Eosinophils promote arterial thrombosis in hematopoietic LNK deficiency.Eosinophil LNK is essential in suppression of arterial thrombosis.
The OncoAlert Newsletter is now out for June 23-29, 2023
Saultier and Michel provide guidance on the risk-stratification, diagnosis, and clinical management principles underpinning care for the ever-increasing nu
Search for official FDA guidance documents and other regulatory guidance for all topics
R. Wendel Naumann, MD, discusses 2 case studies in platinum-resistant ovarian cancer and the optimal treatment approaches for each patient.
What are the symptoms of stomach cancer, and when should you see a doctor about them? Here, surgical oncologist and gastrointestinal cancer specialist Paul Mansfield,…
Abstract. More than ever, scientific progress in cancer research hinges on our ability to combine datasets and extract meaningful interpretations to better understand diseases and…
Data from a phase 2 study may support apalutamide plus androgen deprivation in high-risk localized prostate cancer following radical prostatectomy.
Patients and caregivers will find support and camaraderie at Together Facing Melanoma and Skin Cancer, a free educational workshop. The program will feature a panel…
Elizabeth McKenna: We have an opening on the Cancer Discovery team! / American Association for Cancer Research, cancer, Cancer Discovery team, Elizabeth
Paolo Tarantino: HER2 is about to change again / AstraZeneca, Breast Cancer, cancer, Cancer Discovery, DESTINY-Breast06 Trial, Enhertu, HER2-low Breast